Life Sciences Rise In Value Despite Venture Capital Dropoff
Valuations for life science companies have moved upward this year despite a falloff in venture capital investment, according to Fenwick & West LLP's survey of venture capital financings for 186 U.S.-based...To view the full article, register now.
Already a subscriber? Click here to view full article